Tech Company Financing Transactions

Affinia Therapeutics Funding Round

On 10/8/2025, Affinia Therapeutics raised $40 million in Series C funding from New Enterprise Associates, Alexandria Venture Investments and Atlas Venture.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

43 Foundry Ave. 120
Waltham, MA 02453
USA

Phone

(617) 430-7817

Website

www.affiniatx.com

Email Address

[email protected]

Overview

At Affinia Therapeutics, our purpose is to develop gene therapies that can have a transformative impact on people affected by devastating genetic diseases. Our proprietary platform enables us to methodically engineer novel AAV vectors and gene therapies that have remarkable tissue targeting and other properties.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Rick Modi

        

Chief Medical Officer

Petra Kaufmann

        

Chief Scientific Officer

Charles Albright

        

Chief Technical Officer

Robert May

        

Co-Founder

Botond Roska

        

Co-Founder

Aaron Tward

        

Co-Founder

Luk Vandenberghe

        

VP - Bus. Development

Paula Cobb

        

VP - Bus. Development

Laura Richman

        

VP - General Counsel

Robert Aboud

        

Browse more venture capital transactions:

Prev: 10/8/2025: Nava Benefits venture capital transaction
Next: 10/8/2025: Membrion venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary